"In a healthcare environment, water needs to be held to a much higher standard than tap or bottled water can typically provide. Bottled water has additional issues with low water volumes and plastic waste. Our ultra-purifying filter (with a 0.005 micrometers membrane) far exceeds the CDC recommendation of 0.2 micrometers(bacterial) filtration, producing biologically safer water for sinks, showers, and a broad range of related water applications," said Joleen Turner, Nephros's Vice President of Marketing.
The Nephros DSU point-of-use filter was installed and tested at major northeast medical centers as a proactive measure to prevent the spread of Legionella and other potentially lethal pathogens. The DSU filter provided an effective barrier against waterborne microbial contamination and demonstrated exceptional product longevity.
About Nephros, Inc.
Nephros, Inc., headquartered in New York, is a medical device company developing and marketing products designed to improve the quality of life for the End-Stage Renal Disease (ESRD) patient, while addressing the critical financial and clinical needs of the care provider. ESRD is a disease state characterized by the irreversible loss of kidney function. Nephros products are sold and distributed throughout Europe and are currently being used in over fifty clinics in Europe.
Nephros also markets a line of water filtration products incorporating
its patented dual stage cold sterilization filtration technology, the Dual
Stage Ultrafilter (DSU), which produces biologically safe water. The DSU
has the capability to filter out bacteria and, due to its exceptional
|SOURCE Nephros, Inc.|
Copyright©2008 PR Newswire.
All rights reserved